Combining gene expression analysis of gastric cancer cell lines and tumor specimens to identify biomarkers for anti-HER therapies-the role of HAS2, SHB and HBEGF.

BMC Cancer · 2022 · PMC8908634 · PMID 35264144

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

The Kaplan–Meier curves showed a trend towards better overall survival with HAS2 or SHB expression above the optimized threshold in patients not treated with trastuzumab (Fig.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.